Citations

Mayo Clinic

Showing 10 of 108602 citations.

Outcomes and Patient Experience in Individuals With Longstanding Dizziness
Shah, Manami , Eggers, Scott D.Z. , Lohse, Christine M. , McCaslin, Devin L. , Staab, Jeffrey, Anderson, Ann, Eggers, Scott D, Lohse, Christine, Staab, Jeffrey P. , Anderson, Ann

American Journal of Audiology | April 20, 2023 | Volume: 32 | Issue: 3S | Pages: 721-729

10.1044/2023_aja-22-00152 | PMID 37079889 Get It

Purpose: This study aimed to describe the relationship between changes in pre and post self-perceived dizziness handicap, scores on the patient health questionnaire, and perceptions of patient's value of being evaluated and managed by a multidisciplinary team. Method: Seventy-eight patients completed the Dizziness Handicap Inventory (DHI) and Patient Health Questionnaire–Fourth Edition (PHQ-4) questionnaires post multidisciplinary clinical consultations and testing for the chief complaints of dizziness, unsteadiness, vertigo, or balance problems. The diagnoses of each patient were recorded from the clinical reports of each specialty consultation and were classified as structural, functional, or psychiatric. They were contacted by phone at least 6 months after their visit to obtain feedback regarding their symptoms and overall patient experience. Results: The change in DHI total score did not differ significantly by diagnosis ( p = .56), indicating that patients experienced an improvement in DHI total score regardless of diagnosis. PHQ-4 anxiety scores worsened by a mean of 0.7 points for those with structural diagnoses ( p = .04), improved by a mean of 0.7 points for psychiatric diagnoses ( p = .16), and improved by a mean of 0.3 points for functional diagnoses ( p = .39). Only seven patients would not recommend the team to a family or friend; these patients tended to report worsening DHI total scores ( p = .27) compared to the significant improvement in DHI total scores for patients who would make such a recommendation ( p < .001). Similarly, only 13 patients did not feel the information they received had a positive impact; these patients tended to report worsening DHI total scores ( p = .18) compared to the significant improvement in DHI total scores for patients who did feel the information had a positive impact ( p < .001). Discussion: The assessment and management of patients with chronic dizziness is challenging due to symptoms arising from multiple etiologies. Our finding of a vast difference between high satisfaction and relatively unchanged dizziness handicap suggests that there is value in seeing a multidisciplinary team where consultations are unhurried, care is coordinated, and expectations regarding treatment can be managed.
Vesicourethral Anastomotic Stenosis Following Radical Prostatectomy: Risk Factors, Natural History, and Treatment Outcomes
Britton, Cameron J. , Sharma, Vidit , Fadel, Anthony , Bearrick, Elizabeth , Frank, Igor, Tollefson, Matthew K. , Karnes, R. Jeffrey , Fadel, Anthony E, Viers, Boyd R. , Fadel, Anthony , Findlay, Bridget L.

Journal of Urology | April 20, 2023 | Volume: 210 | Issue: 2 | Pages: 312-322

10.1097/ju.0000000000003488 | PMID 37079876 Get It

CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization
Luebker, Sarah, Frech, Tracy , Skaug, Brian , Gordon, Jessica , Lakin, Kimberly S. , Bernstein, Elana J. , Luo, Yiming , Steen, Virginia , Moore, Duncan F. , Khanna, Dinesh , Castelino, Flavia V. , Chung, Lorinda, Kapoor, Puneet, Hant, Faye N. , Shanmugam, Victoria K. , VanBuren, John M. , Alvey, Jessica S. , Harding, Monica, Shah, Ankoor R. , Lebiedz‐Odrobina, Dorota, Thomas, Julie K. , Volkmann, Elizabeth R. , Molitor, Jerry A., Sandorfi, Nora , Chung, Leland W.K. , Luo, Yiming , Frech, Tracy M , Skaug, Brian , Bernstein, Elana J , Richardson, Carrie , Khanna, Dinesh , Volkmann, Elizabeth R , Chung, Lorinda , Luo, Yiming , Assassi, Shervin , Luo, Yiming, Shah, Ami A. , Hummers, Laura K , Chung, Lorinda, Shah, Ankoor, Makol, Ashima , Thomas, Julie K

Rheumatology | April 20, 2023 | Volume: 62 | Issue: 10 | Pages: 3433-3438

10.1093/rheumatology/kead176 | PMID 37079727 Get It

Abstract Objectives SSc is associated with increased health-care resource utilization and economic burden. The Collaborative National Quality and Efficacy Registry (CONQUER) is a US-based collaborative that collects longitudinal follow-up data on SSc patients with &lt;5 years of disease duration enrolled at scleroderma centres in the USA. The objective of this study was to investigate the relationship between gastrointestinal tract symptoms and self-reported resource utilization in CONQUER participants. Methods CONQUER participants who had completed a baseline and 12-month Gastrointestinal Tract Questionnaire (GIT 2.0) and a Resource Utilization Questionnaire (RUQ) were included in this analysis. Patients were categorized by total GIT 2.0 severity: none-to-mild (0–0.49); moderate (0.50–1.00), and severe-to-very severe (1.01–3.00). Clinical features and medication exposures were examined in each of these categories. The 12-month RUQ responses were summarized by GIT 2.0 score categories at 12 months. Results Among the 211 CONQUER participants who met the inclusion criteria, most (64%) had mild GIT symptoms, 26% had moderate symptoms, and 10% severe GIT symptoms at 12 months. The categorization of GIT total severity score by RUQ showed that more upper endoscopy procedures and inpatient hospitalization occurred in the CONQUER participants with severe GIT symptoms. These patients with severe GIT symptoms also reported the use of more adaptive equipment. Conclusion This report from the CONQUER cohort suggests that severe GIT symptoms result in more resource utilization. It is especially important to understand resource utilization in early disease cohorts when disease activity, rather than damage, primarily contributes to health-related costs of SSc.
Economic Burden of Fatigue in Inflammatory Bowel Disease
Ananthakrishnan, Ashwin N. , Desai, Raj , Lee, Wan‐Ju , Griffith, Jenny, Chen, Naijun, Loftus, Edward V. , Ananthakrishnan, A N , Loftus, Edward V

Crohn's & Colitis 360 | April 20, 2023 | Volume: 5 | Issue: 3 | Pages: No page available

10.1093/crocol/otad020 | PMID 37663925 Get It

AbstractBackgroundThis retrospective study gathered medical/pharmacy claims data on patients with inflammatory bowel disease (IBD) between January 01, 2000 and March 31, 2019 from the IBM MarketScan commercial claims database to assess the real-world impact of fatigue on healthcare costs in patients newly diagnosed with IBD.MethodsEligible participants were ≥18 years, newly diagnosed with IBD (≥2 separate claims), and had ≥12 months of continuous database enrollment before and after fatigue diagnosis. The date of fatigue diagnosis was the index date; participants were followed for 12 months post-index. Patients with (cases) or without (controls) fatigue were matched 1:1 by propensity score matching. Patients with evidence of prior IBD diagnosis/treatment, or those with a chronic disease other than IBD wherein fatigue is the primary symptom, were excluded. Healthcare resource utilization (HCRU), including hospitalizations, inpatient and outpatient visits, and associated costs were compared between cases and controls.ResultsMatched IBD cohorts (21 321 cases/21 321 controls) were identified (42% Crohn’s disease [CD] and 58% ulcerative colitis [UC]) with similar baseline characteristics (average age: 46 years; 60% female). Cases versus controls had significantly more all-cause outpatient visits (incidence rate ratio [IRR], 95% confidence intervals [95% CI]: 1.64 [1.61, 1.67], P &lt; .001) and all-cause hospitalizations (IRR [95% CI]: 1.92 [1.81, 2.04], P &lt; .001); as well as significantly higher all-cause total direct healthcare costs (mean: $24 620 vs. $15 324; P &lt; .001). Similar findings were observed for IBD-related outcomes, as well as in CD- and UC-specific subgroups.ConclusionsPresence of fatigue is associated with an increase in HCRU and total medical costs among patients newly diagnosed with IBD.
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial
Duong, Vu H. , Ruppert, Amy S. , Borate, Uma , Stein, Eytan M. , Baer, Maria R. , Kovacsovics, Tibor , Blum, William , Arellano, Martha , Schiller, Gary J. , Olin, Rebecca L. , Foran, James M. , Litzow, Mark R. , Patel, Prapti A. , Redner, Robert L. , Al‐Mansour, Zeina , Swords, Ronan , Collins, Robert H. , Vergilio, Jo‐Anne, Heerema, Nyla A. , Rosenberg, Leonard, Yocum, Ashley O. , Marcus, Sonja, Druggan, Franchesca , Stefanos, Mona , Gana, Theophilus J. , Burd, Amy , Byrd, John C. , Levine, Ross L. , Boyiadzis, Michael , Byrd, John C. , Blum, William , Arellano, Martha L , Foran, James M , Lin, Tara L , Gana, Theophilus J , Duong, Vu H , Byrd, John C , Mims, Alice S , Stock, Wendy , Lin, Tara L. , Foster, Matthew C , Cogle, Christopher Ramin , Chen, Timothy Frank , Shoben, Abigail B. , Druker, Brian J

Cancer | April 20, 2023 | Volume: 129 | Issue: 15 | Pages: 2308-2320

10.1002/cncr.34780 | PMID 37078412 Get It

AbstractBackgroundPatients with acute myeloid leukemia (AML) who have tumor protein p53 (TP53) mutations or a complex karyotype have a poor prognosis, and hypomethylating agents are often used. The authors evaluated the efficacy of entospletinib, an oral inhibitor of spleen tyrosine kinase, combined with decitabine in this patient population.MethodsThis was a multicenter, open‐label, phase 2 substudy of the Beat AML Master Trial (ClinicalTrials.gov identifier NCT03013998) using a Simon two‐stage design. Eligible patients aged 60 years or older who had newly diagnosed AML with mutations in TP53 with or without a complex karyotype (cohort A; n = 45) or had a complex karyotype without TP53 mutation (cohort B; n = 13) received entospletinib 400 mg twice daily with decitabine 20 mg/m2 on days 1–10 every 28 days for up to three induction cycles, followed by up to 11 consolidation cycles, in which decitabine was reduced to days 1–5. Entospletinib maintenance was given for up to 2 years. The primary end point was complete remission (CR) and CR with hematologic improvement by up to six cycles of therapy.ResultsThe composite CR rates for cohorts A and B were 13.3% (95% confidence interval, 5.1%–26.8%) and 30.8% (95% confidence interval, 9.1%–61.4%), respectively. The median duration of response was 7.6 and 8.2 months, respectively, and the median overall survival was 6.5 and 11.5 months, respectively. The study was stopped because the futility boundary was crossed in both cohorts.ConclusionsThe combination of entospletinib and decitabine demonstrated activity and was acceptably tolerated in this patient population; however, the CR rates were low, and overall survival was short. Novel treatment strategies for older patients with TP53 mutations and complex karyotype remain an urgent need.
An overview of the resilience world: Proceedings of the American Geriatrics Society and National Institute on Aging State of Resilience Science Conference
Bandeen‐Roche, Karen , Bergeman, C. S. , Bennett, David A. , Davis, Daniel , Kind, Amy , Whitson, Heather E. , Bennett, David A. , LeBrasseur, Nathan, Abadir, Peter , LeBrasseur, Nathan K. , Stern, Yaakov , Varadhan, Ravi

Journal of the American Geriatrics Society | April 20, 2023 | Volume: 71 | Issue: 8 | Pages: 2381-2392

10.1111/jgs.18388 | PMID 37079440 Get It

Abstract Resilience, which relates to one's ability to respond to stressors, typically declines with age and the development of comorbid conditions in older organisms. Although progress has been made to improve our understanding of resilience in older adults, disciplines have employed different frameworks and definitions to study various aspects of older adults' response to acute or chronic stressors. “Overview of the Resilience World: State of the Science,” a bench‐to‐bedside conference on October 12–13, 2022, was sponsored by the American Geriatrics Society and National Institute on Aging. This conference, summarized in this report, explored commonalities and differences among the frameworks of resilience most commonly used in aging research in the three domains of resilience: physical, cognitive, and psychosocial. These three main domains are intertwined, and stressors in one domain can lead to effects in other domains. The themes of the conference sessions included underlying contributors to resilience, the dynamic nature of resilience throughout the life span, and the role of resilience in health equity. Although participants did not agree on a single definition of “resilience(s),” they identified common core elements of a definition that can be applied to all domains and noted unique features that are domain specific. The presentations and discussions led to recommendations for new longitudinal studies of the impact of exposures to stressors on resilience in older adults, the use of new and existing cohort study data, natural experiments (including the COVID‐19 pandemic), and preclinical models for resilience research, as well as translational research to bring findings on resilience to patient care.
Commentary: Daily Pain Prediction Using Smartphone Speech Recordings of Patients With Spine Disease
Bydon, Mohamad , Johnson, Sarah E. , Katsos, Konstantinos, Katsos, Konstantinos D.

Neurosurgery | April 20, 2023 | Volume: 93 | Issue: 3 | Pages: e61-e62

10.1227/neu.0000000000002503 | PMID 37078725 Get It

Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn’s disease and leads to impaired CFB cleavage and phagocytosis
Akhlaghpour, Marzieh, Haritunians, Talin , More, Shyam K., Thomas, Lisa , Stamps, Dalton T., Dube, Shishir, Li, Dalin , Yang, Shaohong, Landers, Carol J., Hamade, Hussein , Murali, Ramachandran , Potdar, Alka A. , Wolf, Andrea J. , Botwin, Gregory J., Khrom, Michelle , Faubion, William A. , Jabrì, Bana , Lira, Sérgio A. , Newberry, Rodney D. , Sandler, Robert S. , Sartor, R. Balfour , Xavier, Ramnik J. , Lazarev, Mark , Rioux, John D. , Silverberg, Mark S. , Zaghiyan, Karen , Fleshner, Phillip , Melmed, Gil , Vasiliauskas, Eric A., Ha, Christina , Rabizadeh, Shervin , Syal, Gaurav , Bonthala, Nirupama , Ziring, David , Targan, Stephan R. , Long, Millie D. , Michelsen, Kathrin S. , Nöthen, Markus M. , Ellinghaus, David , D’Amato, Mauro , Halfvarson, Jonas , Lee, James , Limbergen, Johan Van , Mowat, Craig , Hamade, Hussein , Ananthakrishnan, A N , Lira, Sergio A , Cho, Judy H , Michelsen, Kathrin S , Haritunians, Talin , Ellinghaus, David , D'Amato, Mauro , Nöthen, Markus M , Sandler, Robert S , Melmed, Gil Y , Halfvarson, Jonas , Newberry, Rodney D , Rioux, John D , Mengesha, Emebet , Ananthakrishnan, Ashwin N. , Jabrì, Bana , Brant, Steven R , Duerr, Richard H , Schumm, L. Philip , McGovern, Dermot , Lee, James C.

Gut | April 20, 2023 | Volume: 72 | Issue: 11 | Pages: 2068-2080

10.1136/gutjnl-2023-329689 | PMID 37080587 Get It

Objective Perianal Crohn’s disease (pCD) occurs in up to 40% of patients with CD and is associated with poor quality of life, limited treatment responses and poorly understood aetiology. We performed a genetic association study comparing CD subjects with and without perianal disease and subsequently performed functional follow-up studies for a pCD associated SNP in Complement Factor B ( CFB ). Design Immunochip-based meta-analysis on 4056 pCD and 11 088 patients with CD from three independent cohorts was performed. Serological and clinical variables were analysed by regression analyses. Risk allele of rs4151651 was introduced into human CFB plasmid by site-directed mutagenesis. Binding of recombinant G252 or S252 CFB to C3b and its cleavage was determined in cell-free assays. Macrophage phagocytosis in presence of recombinant CFB or serum from CFB risk, or protective CD or healthy subjects was assessed by flow cytometry. Results Perianal complications were associated with colonic involvement, OmpC and ASCA serology, and serology quartile sum score. We identified a genetic association for pCD (rs4151651), a non-synonymous SNP (G252S) in CFB , in all three cohorts. Recombinant S252 CFB had reduced binding to C3b, its cleavage was impaired, and complement-driven phagocytosis and cytokine secretion were reduced compared with G252 CFB. Serine 252 generates a de novo glycosylation site in CFB. Serum from homozygous risk patients displayed significantly decreased macrophage phagocytosis compared with non-risk serum. Conclusion pCD-associated rs4151651 in CFB is a loss-of-function mutation that impairs its cleavage, activation of alternative complement pathway, and pathogen phagocytosis thus implicating the alternative complement pathway and CFB in pCD aetiology.
COVID-19: Factors Associated with the Psychological Distress, Fear and Resilient Coping Strategies among Community Members in Saudi Arabia
Alharbi, Talal Ali F. , AlQurashi, Alaa , Mahmud, Ilias , Alharbi, Rayan Jafnan , Islam, Sheikh Mohammed Shariful , Almustanyir, Sami , Maklad, Ahmed Essam , AlSarraj, Ahmad, Mughaiss, Lujain Nedhal, Al‐Tawfiq, Jaffar A. , Ahmed, Ahmed Ali , Barry, Mazin , Alabdan, Lulwah Ibrahim, Alif, Sheikh Mohammad , Sultana, Farhana , Salehin, Masudus , Banik, Biswajit , Rahman, Muhammad Aziz , Alqurashi, Alaa Ashraf Bagader , Alif, Sheikh M , Salehin, Masudus , Rahman, Muhammad Aziz , Islam, Sheikh Mohammed Shariful , Ghozy, Sherief , Cross, Wendy M

Healthcare | April 20, 2023 | Volume: 11 | Issue: 8 | Pages: 1184

10.3390/healthcare11081184 | PMID 37108018 Get It

(1) Background: COVID-19 caused the worst international public health crisis, accompanied by major global economic downturns and mass-scale job losses, which impacted the psychosocial wellbeing of the worldwide population, including Saudi Arabia. Evidence of the high-risk groups impacted by the pandemic has been non-existent in Saudi Arabia. Therefore, this study examined factors associated with psychosocial distress, fear of COVID-19 and coping strategies among the general population in Saudi Arabia. (2) Methods: A cross-sectional study was conducted in healthcare and community settings in the Saudi Arabia using an anonymous online questionnaire. The Kessler Psychological Distress Scale (K-10), Fear of COVID-19 Scale (FCV-19S) and Brief Resilient Coping Scale (BRCS) were used to assess psychological distress, fear and coping strategies, respectively. Multivariate logistic regressions were used, and an Adjusted Odds Ratio (AOR) with 95% Confidence Intervals (CIs) was reported. (3) Results: Among 803 participants, 70% (n = 556) were females, and the median age was 27 years; 35% (n = 278) were frontline or essential service workers; and 24% (n = 195) reported comorbid conditions including mental health illness. Of the respondents, 175 (21.8%) and 207 (25.8%) reported high and very high psychological distress, respectively. Factors associated with moderate to high levels of psychological distress were: youth, females, non-Saudi nationals, those experiencing a change in employment or a negative financial impact, having comorbidities, and current smoking. A high level of fear was reported by 89 participants (11.1%), and this was associated with being ex-smokers (3.72, 1.14–12.14, 0.029) and changes in employment (3.42, 1.91–6.11, 0.000). A high resilience was reported by 115 participants (14.3%), and 333 participants (41.5%) had medium resilience. Financial impact and contact with known/suspected cases (1.63, 1.12–2.38, 0.011) were associated with low, medium, to high resilient coping. (4) Conclusions: People in Saudi Arabia were at a higher risk of psychosocial distress along with medium-high resilience during the COVID-19 pandemic, warranting urgent attention from healthcare providers and policymakers to provide specific mental health support strategies for their current wellbeing and to avoid a post-pandemic mental health crisis.
Physical functioning following spinal cord stimulation: a systematic review and meta-analysis
ElSaban, Mariam , Kleppel, Donald J , Kubrova, Eva , Alvarez, Gabriel A Martinez , Hussain, Nasir , D’Souza, Ryan S. , Martinez Alvarez, Gabriel A , D'Souza, Ryan S

Regional Anesthesia & Pain Medicine | April 20, 2023 | Volume: 48 | Issue: 6 | Pages: 302-311

10.1136/rapm-2022-104295 | PMID 37080578 Get It

Background Spinal cord stimulation (SCS) has emerged as an important treatment for chronic pain disorders. While there is evidence supporting improvement in pain intensity with SCS therapy, efforts to synthesize the evidence on physical functioning are lacking. Objective The primary objective of this meta-analysis was to assess long-term physical function following 12 months of SCS for chronic back pain. Evidence review PubMed, EMBASE, Scopus, and CENTRAL databases were searched for original peer-reviewed publications investigating physical function following SCS. The primary outcome was physical function at 12 months following SCS therapy for chronic back pain compared with baseline. A random effects model with an inverse variable method was used. The Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) framework was used to determine the certainty of evidence. Findings A total of 518 studies were screened, of which 36 were included. Twenty-two studies were pooled in the meta-analysis. There was a significant reduction in Oswestry Disability Index (ODI) scores at all time frames up to 24 months following implantation. Pooled results revealed significant improvement in ODI scores at 12 months with a mean difference of −17.00% (95% CI −23.07 to −10.94, p<0.001). There was a very low certainty of evidence in this finding as per the GRADE framework. There was no significant difference in subgroup analyses based on study design (randomised controlled trials (RCTs) vs non-RCTs), study funding, or stimulation type. Conclusion This meta-analysis highlights significant improvements in physical function after SCS therapy. However, this finding was limited by a very low GRADE certainty of evidence and high heterogeneity.